Kevin Vanspranghe 1 – 2 of 2 publications Show 10 5 10 15 20 50 100 250 Sort by year (new to old) Actions Filter publications Download search results Subscribe to news feed Add to list Journal Article A1 open access Non-vitamin K antagonist oral anticoagulants (NOACs) versus warfarin in patients with atrial fibrillation using P-gp and/or CYP450-interacting drugs : a systematic review and meta-analysis Maxim Grymonprez, Kevin Vanspranghe, Stephane Steurbaut, Tine De Backer (UGent) and Lies Lahousse (UGent) (2023) CARDIOVASCULAR DRUGS AND THERAPY. 37(4). p.781-791 Add to list Journal Article A1 open access Impact of P-glycoprotein and/or CYP3A4-interacting drugs on effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation : a meta-analysis Maxim Grymonprez, Kevin Vanspranghe, Andreas Capiau (UGent) , Koen Boussery (UGent) , Stephane Steurbaut and Lies Lahousse (UGent) (2022) BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 88(7). p.3039-3051
